ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "T cell activation"

  • 2019 American Transplant Congress

    Recipient Monocytes Activated by Endobronchial Toll-Like Receptor 2 Agonist Prevent Tolerance Induction after Lung Transplantation

    S. Tanaka1, J. M. Gauthier1, Y. Terada1, T. Takahashi1, W. Li1, R. Higashikubo1, A. Y. Tong1, V. Puri1, A. S. Krupnick2, A. E. Gelman1, D. Kreisel1

    1Department of Surgery, Washington University in St. Louis, St. Louis, MO, 2Department of Surgery, The University of Virginia, Charlottesville, VA

    *Purpose: Extended criteria lung donors are being increasingly utilized, raising the possibility of transplanting lungs with a pre-existing pneumonia; how donor pneumonia alters alloimmune responses,…
  • 2019 American Transplant Congress

    A Novel Method for Ex Vivo Treg Expansion via Human iNKT Cell Activation

    R. Ishii1, I. Masako1, H. Katsumata1, T. Kanzawa1, T. Yamakawa1, H. Ishigooka1, T. Hirai1, K. Saiga1, M. Okumi1, Y. Ishii2, K. Tanabe1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan, 2Vaccine Innovation Laboratory RIKEN Cluster for Science, Technology and Innovation Hub (RCSTI), Kanagawa, Japan

    *Purpose: Tregs play a critical role in immune tolerance. If Tregs can be administered to patients suffering from immune disorders, most therapies employing existing immunosuppressants…
  • 2019 American Transplant Congress

    Efficacy of Photobiomodulatory Therapy Combined with Short-Term Immunosuppressants Prolonged Allograft Survival in a Rodent Hind-Limb Model

    Y. KUO1, Y. Li1, C. Chen1, R. Chen11, G. Brandacher2

    1Division of Plastic Surgery, Department of Surgery,, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2Department of Plastic Surgery, VCA center, Johns Hopkins University, Baltimore, MD

    *Purpose: Photobiomodulation has been applied for accelerating the skeletal muscle repair process. Our formal study demonstrated vitamin D could be involved in allograft survival and…
  • 2019 American Transplant Congress

    Dichotomous Role Of Donor T Cells In The Efficacy Of Tolerogenic Therapies For Transplant Rejection

    M. Iglesias Lozano, D. Bibicheff, M. Chicco, G. Brandacher, G. Raimondi

    Plastic Surgery, Johns Hopkins University, Baltimore, MD

    *Purpose: Costimulation blockade-based regimens are a promising strategy to promote transplant tolerance. However, their efficacy is affected by multiple factors, many of which remain unknown.…
  • 2019 American Transplant Congress

    Beta2-Adrenergic Receptor Activation Prolongs Survival of Vascularized Composite Tissue Allotransplants in a Murine Model

    M. Kim1, D. Fisher1, J. Loo1, P. Bogner2, U. Sharma3, J. Skitzki1, E. Repasky4

    1Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 2Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 3Cardiology, University at Buffalo, Buffalo, NY, 4Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

    *Purpose: Transplantation of faces, hands, and limbs using vascularized composite allotransplantation (VCA) has faced significant challenges hindering its routine implementation in the clinic. One critical…
  • 2019 American Transplant Congress

    ZFYVE21 is a Novel Complement-Induced Rab5 Effector Protein Mediating Cardiac Allograft Vasculopathy

    D. Jane-wit1, C. Fang1, L. Liu1, L. Qin1, G. Guangxin Li1, P. Nigrovic2, G. Tellides3, J. Pober4

    1Dept of Cardiology, Yale University School of Medicine, New Haven, CT, 2Dept of Rheumatology, Immunology, and Allergy, Harvard University, Boston, MA, 3Dept of Surgery, Yale University School of Medicine, New Haven, CT, 4Dept of Immunobiology, Yale University School of Medicine, New Haven, CT

    *Purpose: Complement promotes vascular inflammation in transplant organ rejection, a process leading to cardiac allograft vasculopathy. In this study, we identify a new Rab5 effector…
  • 2019 American Transplant Congress

    High Urinary Neutrophil Gelatinase Lipocalins (NGAL) Levels in Kidney Perfusates as Predictor of a Better Renal Function

    A. Angeletti, C. Donadei, V. De Pace, I. Capelli, V. Corradetti, C. Zannini, F. Alviano, L. Bonsi, G. Comai, M. Ravaioli, G. La Manna

    DIMES, S.Orsola-Malpighi Hospital, Bologna University, Bologna, Italy

    *Purpose: Neutrophil gelatinase-associated lipocalin (NGAL) has recently emerged as a biomarker of different conditions, but the biological role remains unclear. We hypnotized that NGAL has…
  • 2019 American Transplant Congress

    Senescent Cell Clearance with Senolytic Drugs Improves Cardiac Allograft Survival by Targeting mt-DNA Mediated Immune Responses

    J. Iske1, M. Koichiro1, M. Seyda1, T. Heinbokel1, Y. Nian1, R. Maenosono1, H. Azuma1, C. Falk2, T. Tchokonia3, J. Kirkland3, A. Elkhal1, S. Tullius1

    1Transplant Surgery, Brigham and Women's Hospital, Boston, MA, 2Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany, 3Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN

    *Purpose: Older organs represent an underutilized potential. We dissected alloimmune responses when transplanting older organs and tested if the depletion of senescent cells in older…
  • 2019 American Transplant Congress

    Pre-Transplant Donor-Specific IFN-γ ELISPOT as a Predictor of Allograft Rejection: A Diagnostic Test Accuracy Meta-Analysis

    S. Farouk1, I. Gandolfini2, N. Montero3, E. Crespo4, M. Jarque4, M. Meneghini4, U. Maggiore2, O. Bestard3, P. Cravedi1

    1Medicine, Division of Nephrology, Icahn School of Medicine at Mt. Sinai, New York, NY, 2Centro Trapianti Rene-Pancreas, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy, 3Nephrology, Bellvitge University Hospital, Barcelona, Spain, 4Experimental Nephrology Laboratory. IDIBELL, Barcelona, Spain

    *Purpose: Pre-transplant interferon-γ (IFN-γ) enzyme-linked immunospot (IFN- γ ELISPOT) has been proposed as a tool to quantify alloreactivity of memory T cells and estimate the…
  • 2019 American Transplant Congress

    PD-1+CD3+CD4-CD8- (Double Negative T-cells) Are Early Responders during Kidney Ischemia Reperfusion Injury and Regulated by Non-Classical MHC Molecules

    M. Sadasivam, S. Noel, S. Lee, J. Gong, A. Hamad, H. Rabb

    Johns Hopkins University and School of Medicine, Baltimore, MD

    *Purpose: Unconventional T-cells (e.g. Tregs and γδT-cells) are increasingly recognized for their roles in maintaining homeostasis and protecting non-lymphoid tissues against injury/stress. Double negative (DN)…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences